PortfoliosStock ScreensStocksStockXcel

Kilitch Drugs (India) Limited

KILITCH | NSE

138.65

INR

0.30

0.22%

KILITCH | NSE
Loading StockChartView...

About Kilitch Drugs (India) Limited

Sector

Healthcare

Industry

Drug Manufacturers-Specialty & Generic

Earnings date

31/03/2024

As of date

02/04/2026

Close

138.65

Open

138.00

High

139.94

Low

132.20

Kilitch Drugs (India) Limited engages in the development and operation of pharmaceutical business in India. The company offers parenteral and nasal products including gastroenterology anti-inflammatory anticonvulsant/antiepileptic anti-malarial aminoglycoside antibacterial anti-hypertensive anti-infective diagnostic sympathomimetic local anesthetic neurotonic uterine stimulant external preparation non-steroidal anti-inflammatory oncology ophthalmic and other drugs as well as vaccines and veterinary products in the form of ampoules vials and dry powder injectables. Its parenteral and nasal products also include iron supplements for the treatment of anemia; and metered nasal drops as well as Klavmox and Onecef products. The company also provides a range of oral formulations including tablets capsules dry syrup gripe water and oral powder and liquid in the antibiotic anti-diabetics cardiovascular and other areas. In addition it offers effervescent tablets and powders such as ROIPAR DUREGRA ROIVIT and PH-7; and various nutritional products such as CELTINE. Further the company provides C-Seal a topical skin adhesive to hold closely approximated skin edges without marks of sutures and incisions. Additionally it offers cosmetics and herbal products consisting of a range of oils lotions liquids creams and paste in skin personal and hair care categories as well as herbal products used in sore throat and prostate problems; and as a supplement for diabetes obesity libido and other conditions. The company also exports its products. Kilitch Drugs (India) Limited was founded in 1978 and is headquartered in Mumbai India.

View Less

KILITCH | NSE

Risk
193.4
Sharpe
-0.98
Luna's Score
42/100
Recommendation
Sell

Luna says (KILITCH | NSE)

What's Working

Low Market Beta (-0.4 to 0.8)

Low Debt to Equity (< 0.25)

Low Debt to Asset (< 0.2)

What's not Working

Price Below SMA10D

High Short-term Volatility

High 6-Month Volatility (>65%)

Microcap (<300M USD)

Weak Operating Margin (< 10%)

Declining Revenue (< 0%)

Weak Sharpe Ratio (< 0.3)

Volatility Signals

Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.

Risk Meter

Loading RiskMeterView...

10 days

282.4%

1 month

193.4%

3 months

116.2%

6 months

86.2%

Returns

Loading ReturnMeterView...

Fundamental Ratios

PE

42.44

Fwd. PE

-

Price to book

3.03

Debt to equity

0.18

Debt to assets

0.13

Ent. to EBITDA

17.37

Ent. to rev.

3.24

PEG

-

Other Fundamentals

EBITDA

197.37M

MarketCap

2.24B

MarketCap(USD)

24.10M

Div. yield

-

Op. margin

2.41

Erngs. growth

-61.40

Rev. growth

-8.50

Ret. on equity

8.32

Short ratio

-

Short perc.

-

Market Sentiment (SMA and Price signals)

Short-term: Bearish (SMA10D < SMA1M)

Intermediate-term: Bearish (SMA1M < SMA3M)

Long-term: Bearish (SMA6M < SMA12M)

SMAs: Stock Price Trends

Loading MovingAverageView...

Range10D

207.75

Range1M

212.75

Range3M

288.75

Volumes: Market Activity

Volume Averages

Loading VolumeAverageView...

Rel. volume

0.44

Price X volume

1.40M

Peers

Name
Ticker
Industry
Close
Marketcap
Day Return
PE Ratio
Debt to Equity
 
 
 
 
 
 
 
 
Nectar Lifesciences LimitedNECLIFEDrug Manufacturers-Specialty & Generic10.042.28B2.87%138.0759.44%
Lyka Labs LimitedLYKALABSBiotechnology55.531.98B8.52%813.9486.05%
Aarey Drugs & Pharmaceuticals LimitedAAREYDRUGSDrug Manufacturers-Specialty & Generic53.711.56B0.81%32.7523.61%
Brooks Laboratories LimitedBROOKSDrug Manufacturers-Specialty & Generic53.381.42B19.87%n/a8.60%
Alpa Laboratories LimitedALPADrug Manufacturers-Specialty & Generic51.751.09B3.07%13.543.45%
Bal Pharma LimitedBALPHARMADrug Manufacturers-Specialty & Generic65.41.05B0.82%25.83201.53%
Par Drugs And Chemicals LimitedPARDrug Manufacturers-Specialty & Generic82.471.03B-0.19%19.900.00%
Krebs Biochemicals & Industries LimitedKREBSBIODrug Manufacturers-Specialty & Generic47.631.02B7.18%n/a-162.25%
Mangalam Drugs & Organics LimitedMANGALAMDrug Manufacturers-Specialty & Generic29.55477.89M3.68%n/a71.03%
Biofil Chemicals and Pharmaceuticals LimitedBIOFILCHEMDrug Manufacturers-Specialty & Generic27.43458.13M-0.44%181.382.41%
  • 1

Diversifiers

Name
Ticker
Industry
Close
Marketcap
Day Return
PE Ratio
Debt to Equity
 
 
 
 
 
 
 
 
Madhav Copper LimitedMCLCopper60.361.67B4.99%82.2232.14%
Cubex Tubings LimitedCUBEXTUBCopper84.361.23B0.67%35.8521.78%
Touchwood Entertainment LimitedTOUCHWOODAdvertising Agencies66.71743.74M1.24%50.064.88%
Sagardeep Alloys LimitedSAGARDEEPCopper22.45389.73M-1.92%58.6243.14%
Heads UP Ventures LimitedHEADSUPApparel Retail6.97152.71M0.72%n/a0.00%
  • 1

Industry Comparison

ParameterCompanyIndustryIndicator
Enterprise to EBITDA17.3724.85Cheaper
Ent. to Revenue3.2411.40Cheaper
PE Ratio42.4451.36Par
Price to Book3.036.83Cheaper
Dividend Yield-0.52-
Std. Deviation (3M)116.2342.17Riskier
Debt to Equity0.180.35Cheaper
Debt to Assets0.130.17Cheaper
Market Cap2.24B290.82BEmerging
  • 1

Unlock Your Investing Potential

Register with Xstocks

Join over 2,000+ Investors

Register now and embark on your journey to informed and successful investing.

Explore Industry Correlations

Explore Industry Correlations

Uncover Trading and Hedging Opportunities

Gain valuable insights into potential trading opportunities and discover strategic hedging possibilities

Discover Top-Performing Industries

Discover Top performing Industries

Explore Stocks for Short and Long-Term Gains

Uncover opportunities at both short-term and long-term horizons, allowing you to make informed investment decisions.

Follow us @XStocks007